Long Term Outcome of Intravitreal Ranibizumab for ROP

CompletedOBSERVATIONAL
Enrollment

140

Participants

Timeline

Start Date

April 1, 2018

Primary Completion Date

September 1, 2018

Study Completion Date

September 1, 2018

Conditions
Retinopathy of Prematurity
Interventions
OTHER

cycloplegic refraction

"Cycloplegic refraction and the average corneal radius of curvature were performed using a handheld auto kerato-refractometer (Righton Retinomax K-plus2). Refraction was confirmed by retinoscopy and refractive errors were calculated as spherical equivalent and astigmatism in cylinder.~The biometric optic components, including anterior chamber depth, lens thickness, and axial length, were measured using A-scan ultrasound (model Echoscan US-4000 / 500; Nidek)."

Trial Locations (1)

Unknown

Mansoura University, Al Mansurah

All Listed Sponsors
lead

Ameera Gamal Abdelhameed

OTHER

NCT04537065 - Long Term Outcome of Intravitreal Ranibizumab for ROP | Biotech Hunter | Biotech Hunter